EUVIMEDEUVIMED entdecken
Crossref

Synthesis, In Vitro and In Silico Investigation of the Anticancer Potential of Oxindole–Chalcone Derivatives

Atif Husain, Mohd Asif, Tazeen Azaz, Md Ataul Islam, Abdul Rahman Khan, Hossam M Aljawdah, Malik Nasibullah iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202500065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Atif Husain und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Lab-B043, Department of Chemistry, Integral University, Lucknow, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Oxindoles, Indoles, Chalcones. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our research goes to the synthesis of oxindole–chalcone derivatives as anticancer molecules under the Claisen–Schmidt reaction. The drug‐likeness properties of synthesized compounds ( 3a – e ) were demonstrated using an online tool named ADME/T. However, the elaboration of anticancer effects of synthesized compounds ( 3a – e ) was successfully reported with the National Cancer Institute (NCI‐60), USA, at 10 µM concentration. As a result, synthesized compound 3c was found to be the most active anticancer agent, which showed 42.48% growth inhibition (GI) against the UO‐31 renal cancer cell line. On the contrary, compound 3a showed 29.14% GI against the SNB‐75 cell line of CNS cancer. Therefore, we chose the renal cancer‐related protein PDB ID: 5GRN for distinguishing the binding score of docked complexes with their comparative study using a standard drug sunitinib. After the docking analysis, the best binding scores are found to be −10.1 kcal/mol for 3a‐5GRN, −9.7 kcal/mol for 3b‐5GRN, −10.3 kcal/mol for 3c‐5GRN, −10.0 kcal/mol for 3d‐5GRN, −10.4 kcal/mol for 3e‐5GRN and −10.1 kcal/mol for control drug sunitinib‐5GRN docked complexes, respectively. The molecular dynamics (MD) simulation incorporating 3c and sunitinib in association with PDGFA (PDB ID: 5GRN) elucidated the potential effectiveness of these compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsOxindolesIndolesChalconesChalconeHumansMolecular Docking SimulationCell ProliferationDrug Screening Assays, AntitumorCell Line, TumorStructure-Activity RelationshipMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

UO‐31anticancerchalconesisatinrenal cancersynthesis

Substanzen

Antineoplastic AgentsOxindoles2-oxindoleIndolesChalconesChalcone

Autor:innen und Institutionen

  • Research Lab-B043, Department of Chemistry, Integral University, Lucknow, India.
  • Quantum DNA Dye Synthesis Research Group, Micron School of Materials Science and Engineering, Boise State University, Boise, Idaho, USA.
  • SilicoScientia Private Limited, Bengaluru, India.
  • Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Malik Nasibullah

Zitieren

APA

Husain, A., Asif, M., Azaz, T., Islam, M. A., Khan, A. R., Aljawdah, H. M., & Nasibullah, M. (2025). Synthesis, In Vitro and In Silico Investigation of the Anticancer Potential of Oxindole–Chalcone Derivatives. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500065

Vancouver

Husain A, Asif M, Azaz T, Islam MA, Khan AR, Aljawdah HM, et al. Synthesis, In Vitro and In Silico Investigation of the Anticancer Potential of Oxindole–Chalcone Derivatives. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500065

BibTeX
@article{Husain2025,
  author = {Husain, Atif and Asif, Mohd and Azaz, Tazeen and Islam, Md Ataul and Khan, Abdul Rahman and Aljawdah, Hossam M and Nasibullah, Malik},
  title = {Synthesis, In Vitro and In Silico Investigation of the Anticancer Potential of Oxindole–Chalcone Derivatives},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202500065}
}
Kostenlos starten →